Search PubMed⌕ Search

Biomedical subjects

J Takeuchi

Publications and source records attributed to J Takeuchi.

At least 217 records · Page 12Linked to original sources

Hemodynamic effects of molsidomine on weight sustaining isometric exercise in patients with ischemic heart disease.

Hemodynamic effects of 2 mg of sublingual molsidomine were evaluated in 11 patients with ischemic heart disease using a weight-sustaining isometric exercise (WSIE) that we developed. Left ventricular end diastolic pressure (LVEDP), mean pulmonary pressure, mean systemic arterial pressure (mAP), cardiac index and stroke work index increased significantly during WSIE before and after molsidomine. Although WSIE resulted in a similar rise of mAP before and after molsidomine, the increment value of LVEDP during WSIE was significantly lower after molsidomine. The recovery time to the resting state of all parameters was shorter and the left ventricular function curves showed a leftward deviation with molsidomine. In conclusion, the results suggest that molsidomine will produce a preload reduction and improve the left ventricular function during WSIE in patients with ischemic heart disease.

Adult↗

Intraglomerular uptake of platelets in unilateral Masugi nephritis in the rabbit.

The pathogenetic roles of platelets were studied in unilateral progressive Masugi nephritis in the rabbit. On fourteenth day after the injection of anti-kidney serum, peripheral platelet counts, platelet aggregation and platelet aggregation rate were not changed statistically compared with those before the initial injection. The presence of platelet antigen within the glomeruli of the unclamped nephritic kidney suggests the participation in the pathogenesis of glomerular lesion. No significant difference was observed in the intrarenal uptake of 111Indium-labeled platelets between clamped and unclamped kidneys. This is probably due to the possibility of the participation of the very small amount of platelets or the possible decreased renal blood flow in the nephritic side in this model, or the active uptake of platelet not being found in this progressed stage of this model.

Animals↗

Serum antibodies against alcohol-treated rabbit hepatocytes in patients with alcoholic liver disease.

The existence of antibodies against alcohol-treated rabbit hepatocytes in sera of patients with alcoholic liver disease was investigated utilizing a 125I-labelled protein A assay. The sera, after two absorptions with normal rabbit hepatocytes, were incubated with hepatocytes isolated from rabbits which had been treated for 4 days with a daily dose of ethanol (1 g/kg body weight) intravenously. Serum antibodies against alcohol-treated hepatocytes were detected in 21 of 55 patients with alcoholic liver disease; this was associated with a distinct, mixed granular and linear fluorescence staining the surface of alcohol-treated hepatocytes. By contrast, none of 23 patients with other liver diseases who had no history of excessive alcohol intake showed the antibodies in their sera. The values of the antibodies of patients with alcoholic active cirrhosis and alcoholic hepatitis were significantly higher than those of other types of alcoholic liver disease. These results showed that antibodies against alcohol-treated hepatocytes are present in alcoholic liver disease with inflammation. The role of these antibodies on liver cell damage in alcoholic liver disease remains to be clarified.

Animals↗

Discriminant analysis in renal histological diagnosis of primary glomerular diseases.

Differences in clinical and laboratory findings between different renal histological lesions were examined in 138 patients with primary glomerular diseases, and discriminant analysis was carried out in 72 patients to determine whether each histological type could be distinguished by the linear combination of these findings. The histological types were classified into 7 groups: minimal change nephrotic syndrome (MCNS); focal glomerular sclerosis (FGS); membranous nephropathy (MN); membranoproliferative GN (MPGN); proliferative GN (PGN); PGN with focal crescents (P X fc); and minor glomerular lesions (MGL). Ten variantes were selected from the clinical and laboratory findings in the early stage of the disease: sex, age of onset, acute onset, oliguria, urine protein, RBC in urinary sediment, serum albumin, serum total cholesterol, serum creatinine, and systolic blood pressure. In the discriminant analysis made regarding all these items collectively as continuous variantes, there was a significant difference (p less than 0.001) in the combination patterns of the variantes among histological types. Therefore, further analysis was performed using canonical axes and a multi-stage discriminant method. The canonical score and data obtained by a multi-stage discriminant method demonstrated that MCNS, MN, MPGN, and the group of PGN, P X fc and MGL could be distinguished from each other well, but that the degree of proliferation or the presence of focal lesions could not be predicted. As a result of these studies, we obtained a discriminant formula with which we could predict, with fairly high accuracy, some histological types on the basis of data on the 10 items mentioned.

Adolescent↗

Plasma concentrations of fibrinopeptide A and fibrinopeptide B beta 15-42 in glomerulonephritis and the nephrotic syndrome.

Plasma fibrinopeptide A (FPA) and fibrinopeptide B beta 15-42 concentrations were determined by radioimmunoassay in 46 patients with glomerulonephritis and the nephrotic syndrome. An increase in plasma FPA and B beta 15-42 levels was noted in these patients; this increase was marked in the nephrotic patients. There was a positive correlation in these patients between plasma FPA and B beta 15-42 levels. The B beta 15-42/FPA ratio was significantly higher in nonnephrotic patients compared with controls. Intravascular coagulation with subsequent fibrinolysis to regulate fibrin formation may occur in patients. A positive correlation was found between plasma B beta 15-42 level and serum urea nitrogen or serum creatinine concentration, suggesting that plasma B beta 15-42 level is influenced not only by plasmin action, but also by renal dysfunction.

Adolescent↗

Clinical evaluation of urapidil, a new antihypertensive drug: preliminary findings in Japan.

The pharmacokinetics, hypotensive effects, and safety of urapidil were investigated in 22 patients with essential hypertension at four coordinated centers in Japan. The drug was administered in sustained-release capsules given twice daily. The peak plasma concentration of the drug (measured in six patients) was observed four to six hours after administration, and 60% to 70% of the peak concentration was detectable at eight hours. These findings suggest that blood pressure might be controlled by twice-daily administration of urapidil. In 14 outpatients, who received 40 to 80 mg/day of urapidil, systolic and mean blood pressure decreased significantly (P less than 0.05) by week 4, and systolic, diastolic, and mean blood pressure decreased significantly (P less than 0.001) by week 6. In four inpatients, treated with 60 to 120 mg/day of the drug for two weeks, there were significant decreases (P less than 0.05) in systolic, diastolic, and mean blood pressure at day 6 and significant decreases (P less than 0.01) in diastolic and mean blood pressure at day 13. Although side effects were noted in five (23%) of the 22 patients, they were transient and slight in three; in two patients, the side effects disappeared after use of the medication was discontinued. Because the study was carried out in a small number of patients who received different dosages of urapidil over a short period of time, the optimal dosage was not established.

Adult↗

Effects of serotonin depleters on the contents of beta-endorphin, alpha-melanotropin and adrenocorticotropin in rat brain and pituitary.

Serotonin depleters, 5,7-dihydroxytryptamine (5,7-DHT) and p-chlorophenylalanine (PCPA), were injected into adult male rats and beta-endorphin (beta-EP), alpha-melanotropin (alpha-MSH) and adrenocorticotropin (ACTH) levels in rat brain and pituitary were each estimated by radioimmunoassay combined with a gel column chromatography. (1) 5,7-DHT, injected intracerebroventricularly combined with pargyline, decreased the levels of immunoreactive-beta-EP, -alpha-MSH and -ACTH significantly and concomitantly in hypothalamus, thalamus, and brainstem. (2) PCPA, repeatedly injected intraperitoneally 8 times every 3 days, decreased the levels of these peptides in some of these brain regions. (3) There was no significant change of IR-beta-EP, -alpha-MSH, -ACTH in the anterior and the intermediate-posterior pituitaries after the treatment of 5,7-DHT or PCPA. (4) A single injection of the same dose of PCPA induced no significant effects on these peptide levels in both brain and pituitary. These data suggest that central serotoninergic neurons might affect beta-EP-alpha-MSH-ACTH containing neurons in rat brain.

5,7-Dihydroxytryptamine↗

Histochemical studies of intercellular components of salivary gland tumors with special reference to glycosaminoglycan, laminin and vascular elements.

In 41 salivary gland tumors, the characteristics of the intercellular components and vascular endothelial cells were surveyed by immunohistochemical staining for laminin and factor VIII-related antigen (VIII R:Ag), and by mucopolysaccharidase-digestion for glycosaminoglycan (GAG). In myxomatous areas of pleomorphic adenomas, small vessels (diameter 6.5 +/- 0.11 micron) were frequent and found to be negative or weakly positive by VIIIR:Ag staining although endothelial cells were clearly positive for VIIIR:Ag in capsule surrounding the tumor tissues. Alcian blue stainability was diminished by treatment with both Streptomyces hyaluronidase and chondroitinase. By laminin staining, a vascular pattern was clearly detected, but the majority of tumor cells were not stained. In adenomatous areas, the basement membrane-like linear laminin-staining reaction was observed to be weak and inconsistent around some tumor cell nests. However, in adenoid cystic carcinomas, laminin-positivity was much more intense than in other tumors such as pleomorphic adenoma, mucoepidermoid tumor and adenocarcinoma. In cylindromatous areas, the inner luminal surface in the pseudocysts was markedly positive for laminin, and there was weak positivity around tumor cell nests having a trabecular pattern. By immunoelectron microscopy, a juxtacellular network of replicated basal lamina of tumor cells which lined the inner surface of pseudocysts was positive for laminin. Alcian blue-positivity in the pseudocyst was abolished with heparitinase and chondroitinase, but not with hyaluronidase.

Adenocarcinoma↗

Single agent therapy of interferon for brain tumours: correlation between natural killer activity and clinical course.

The anti-tumour effect of mouse interferon (IFN) on an intracranially transplanted 203-glioma in C 57BL mice and the natural killer (NK) activity of spleen cells were studied. As a clinical trial, five patients with glioblastomas were treated with human fibroblast IFN and the anti-tumour effect of IFN and the NK activity of peripheral blood lymphocytes were also studied. The NK activity increased after the beginning of IFN therapy but there was no remarkable anti-tumour effect of IFN in both mouse and human studies. There was no marked correlation between the increased NK activity and the anti-tumour effect of IFN in this study.

Adult↗

STA-MCA anastomosis in patients with skull base tumours involving the internal carotid artery--haemodynamic assessment by ultrasonic Doppler flowmeter.

The role of superficial temporal artery--middle cerebral artery (STA-MCA) anastomosis was investigated with an ultrasonic Doppler flowmeter in 3 patients with sphenoid ridge meningiomas and one with a parasellar malignant teratoma, all of which involved the intracranial internal carotid artery. The intraoperative Doppler flow study revealed a remarkable increase in flow volume of the STA after trial occlusion of the middle cerebral artery in one case and permanent occlusion in two cases. These results substantiate the effectiveness of STA-MCA anastomosis. We also discuss surgical and other contrivances for obtaining sufficient blood supply from this bypass to prevent cerebral ischaemia in the acute phase after elective or accidental occlusion of a major cerebral artery. This is the first report of STA-MCA anastomosis in cases with brain tumour.

Carotid Artery Diseases↗

Nd-YAG laser as a surgical tool.

As neurological operation has necessitated effective haemostatic devices, CO2 and Nd-YAG lasers have been introduced in this field. The CO2 laser was first studied and used in neurological surgery and many problems, such as safety, mobility, and others, were overcome by pioneers. The Nd-YAG laser has been developed mainly for endoscopic surgery. However, we noticed its strong haemostatic effect, used it in neurosurgery and found it to be quite effective in removing tumours. The following properties of the Nd-YAG laser are especially fitted for neurosurgical surgery: the laser beam is conducted through a light, thin and flexible quartz fibre; penetration of the laser beam into tissues is controlled by the output wattage, and the grade of coagulation is controlled by duration of irradiation time and by the output wattage.

Brain Neoplasms↗

Extent of thermal penetration of Nd-YAG laser--histological considerations.

The extent of thermal penetration of Nd-YAG laser was studied histologically. The material was obtained from seven cases of various types of intracranial and extracranial tumours and normal temporal muscle obtained at operation. After irradiation of the tumour surface with the laser, the tumours were removed and depth and width of pathological changes caused by heat were studied. Histologically, materials consisted of a vaporized surface, carbonized, vesicular, necrotic, oedematous layer and surrounding intact brain tumour tissue. There was a direct relationship between the thermal effect and the irradiated thermal energy (watt x exposure time x pulse number). The results showed that the thermal effect was limited to a depth of 6 to 10 mm from the irradiated surface when irradiated 4 times at the power of 90 watts for 2 seconds.

Adult↗